SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-experiments-amyloid-removal-clinica
Related Entities
experiments-amyloid-removal-clinical-benefit-limited
Metadata
slugexperiments-amyloid-removal-clinical-benefit-limited
entity_typeexperiment
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (47)
derives_from🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti95%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%
related🔬APOE4 differs from APOE3 by C112R causing domain interaction50%
related🧪Glycosaminoglycan Template Disruption Approach50%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro50%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
see_also🧪Glycosaminoglycan Template Disruption Approach50%
see_also🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro50%
see_also🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%
mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub